Item 8.01 Other Events.

On August 4, 2020, the board of directors of the Registrant approved in principle for the Registrant and/or its wholly owned Israeli subsidiary CTGL - Citrine Global Israel Ltd to invest in iBOT: Israel Botanicals, an Israeli botanical nutraceutical company. iBOT has a manufacturing facility for a wide range of botanical formulations, and part of its strategy is to combine this with hemp and CBD.

The board gave its approval for a proposed transaction in which

1. the Registrant will have an option to make one or more investments during a

period of 12 months in an aggregate amount of up to $1,000,000 (one million US

dollars);

2. the investments may be through loans, direct equity purchases, or other means,

and will be based on milestones; and

3. iBOT will grant the Registrant a 25% discount in its next fundraising.

In addition, the board approved for the Registrant to enter a services agreement with iBOT pursuant to which the Registrant will provide consulting and other services to iBOT.

The foregoing remain subject to agreement of definitive terms and receipt of all necessary corporate and other approvals. iBOT is controlled by an affiliate of the Registrant.

© Edgar Online, source Glimpses